Product Images Nexletol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Nexletol NDC 72426-118 by Esperion Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - nexletol 01
Figure 1 - nexletol 02
This text appears to be a report of a clinical trial comparing the effectiveness of Nexletol 180mg with Placebo in reducing LDL Cholesterol levels over a period of 36 weeks. The report displays the mean percent change in LDL Cholesterol levels at baseline and week 36 for the two groups of participants: one group received Nexletol 180mg while the other received a placebo. There were 10 subjects in the Nexletol group and 99 subjects in the Placebo group.*
PRINCIPAL DISPLAY PANEL - 30 Tablet Bottle Label - nexletol 03
This is information about the storage, dosage, and administration of a medication called NEXLETOL (bempedoic acid) fablefs. The package contains 30 tablets, each containing 180 mg of bempedoic acid. It is manufactured by Esperion Therapeutics, Inc. and should be stored at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should be kept in the original package, and the desiccant should not be discarded. For more information on dosage and administration, consult the accompanying Package Insert.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
